Oxbridge Re (NASDAQ:OXBR – Get Free Report) is expected to be announcing its Q1 2026 results after the market closes on Monday, May 11th. Analysts expect Oxbridge Re to post earnings of ($0.03) per share and revenue of $0.70 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Monday, May 11, 2026 at 4:30 PM ET.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last issued its earnings results on Saturday, February 14th. The insurance provider reported $0.02 earnings per share for the quarter. Oxbridge Re had a negative net margin of 80.68% and a negative return on equity of 34.45%. The company had revenue of $0.58 million for the quarter.
Oxbridge Re Trading Down 1.0%
Shares of Oxbridge Re stock opened at $0.97 on Friday. The company has a 50-day moving average of $0.89 and a two-hundred day moving average of $1.15. Oxbridge Re has a 12-month low of $0.66 and a 12-month high of $2.86. The stock has a market cap of $7.86 million, a PE ratio of -3.59 and a beta of 2.05.
Analysts Set New Price Targets
View Our Latest Report on OXBR
Hedge Funds Weigh In On Oxbridge Re
An institutional investor recently bought a new position in Oxbridge Re stock. Virtu Financial LLC purchased a new stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 17,789 shares of the insurance provider’s stock, valued at approximately $32,000. Virtu Financial LLC owned approximately 0.23% of Oxbridge Re at the end of the most recent reporting period. Institutional investors and hedge funds own 5.64% of the company’s stock.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Recommended Stories
- Five stocks we like better than Oxbridge Re
- Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due
- Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches
- Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money
- Water Infrastructure: Why This Boring Sector Could Get Exciting
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
